GWENDOLYN HEGGINS: Open Payments
NPI 1497589873 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$102 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $16 · 2025 $102
Food & beverage: $102
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: COBENFY, ERZOFRI EXTENDED-RELEASE, CAPLYTA, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
